Skip to main content
. 2016 Aug 19;16(3):e371–e374. doi: 10.18295/squmj.2016.16.03.020

Figure 2:

Figure 2:

Serum creatinine levels in a 61-year-old Omani woman with antibody-mediated rejection following a kidney transplant. The patient showed no improvement after six weeks of conventional therapy and was treated with five doses of eculizumab; she became dialysis-free after the first dose. The dotted lines represent the timing of the first and final doses of eculizumab, respectively.